SAN FRANCISCO--(BUSINESS WIRE)--Further defining the future of Age Intervention Medicine™, Nathan Sassover, CEO of HealthMedica Inc., today announced a national partnership with MedQuest of North Salt Lake Utah. The Agreement was confirmed by Jeffery Bray, Chief Executive Officer and Christopher Cantwell, Chief Operating Officer.
Founded in 1996, MedQuest is a long established compounding pharmaceutics group licensed in all 50 states and Puerto Rico acknowledged as one of the largest custom prescription centers in the US among 7,500 pharmacies nationwide.
Chris Cantwell, MedQuest COO commented: “We are pleased to have been selected by HealthMedica and health science visionary Nathan Sassover as the compounding pharmaceutics provider to support HealthMedica’s announced rollout of Longevity Medical Centers nationwide.”
MedQuest CEO Jeffery Bray added: “We were drawn to HealthMedica’s solid commitment ranging from safety, cutting-edge patient results and evidence-based clinically verifiable health enhancement. MedQuest is pleased to provide strategic support in this transformative approach to longevity science and pharmacogenomics based on HealthMedica’s Age Intervention Medicine protocols.”
Founded by technology inventor and health science innovator Nathan Sassover, HealthMedica Inc. and its evolving Longevity Medical Centers unify Age Intervention Medicine™ and evidence-based personalized programs within a physician administered clinical setting.
HealthMedica Longevity Centers address three primary components of the enlarging healthcare challenges confronting 77 million aging Baby Boomers, which encompass age-related degenerative disorders ranging from cognitive decline, mood disorders, and extending to inflammatory / autoimmune diseases, metabolic disorders and cancer.
HealthMedica (www.Healthmedica.com) and its affiliated clinical partners define a transformative model advancing both preventive and interventional therapeutics. HealthMedica’s focus is on Age Management Therapeutics™, a proprietary series of protocols which originated in 2002, and have demonstrated evidence-based clinically validated therapeutic platforms which also integrate the dynamics of Quality of Life aspects within the totality of proactive age intervention.
About Nathan Sassover
Nathan Sassover’s cross-industry innovations, patented inventions and discoveries extend to diverse technology venues ranging from micro-electronics to health sciences to advanced internet broadcast network architecture. His leading edge innovations and patents have created several technology and business sectors, including the multi-billion dollar global Automotive Remote Keyless Security industry.
In the field of life sciences, Nathan Sassover’s discoveries have resulted in medical and therapeutic platforms and clinical developments addressing the neurobiology of aging and disease as well as molecular cancer genetics and DNA programmable pharmaceutics conjoining Neurosystemic Medicine and Epigenetic Therapeutics.